Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Klatskin Tumor × 1 year × Clear all

Phase

Phase 2 7 Phase NA 6 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 31 Carcinoma, Non-Small-Cell Lung 24 Neoplasm Metastasis 18 Breast Neoplasms 17 Prostatic Neoplasms 16 Colorectal Neoplasms 15 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Lung Neoplasms 10 Recurrence 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Ovarian Neoplasms 9 Leukemia, Myeloid, Acute 9 Pancreatic Neoplasms 8 Myasthenia Gravis 8 Melanoma 8 Leukemia 7 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Glioblastoma 6 Fatigue 6 Endometrial Neoplasms 6 Cholangiocarcinoma 6 Multiple Myeloma 5 Mouth Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Laryngeal Neoplasms 5

Interventions

pembrolizumab 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06923475 2025-04-11

NEODISCO

Amsterdam UMC, location VUmc

Phase 2/3 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡